Reports
Sale
Global Home Blood Testing Devices Market Size, Share, Trends: By Type: Glucose Test Kits, Infectious Diseases Test Kits, Cholesterol Test Strips, Drugs of Abuse Test Kits, Coagulation Monitoring Tests, Others; By Age Group: Pediatric, Adult, Geriatric; By Distribution Channel; Regional Analysis; Market Dynamics; Supplier Landscape; 2024-2032
Global Home Blood Testing Devices Market Outlook
The global home blood testing devices market size was valued at USD 16.4 billion in 2023, driven by the rising prevalence of diabetes across the globe. The market is expected to grow at a CAGR of 10.7% during the forecast period of 2024-2032, with the values likely to rise from USD 18.2 billion in 2024 to USD 41.1 billion by 2032.
Home Blood Testing Devices: Introduction
Home blood testing devices are portable medical devices used to monitor blood glucose levels in people who are diabetic, and other tests such as cholesterol levels, blood pressure, hemoglobin levels, and more. The tests are performed by taking blood samples with the help of test strips or cartridges (usually comes with the device kit). The advantage of using home blood testing devices is the ability to monitor health conditions of an individual in real-time, early detection of abnormalities or changes in blood parameters, and the convenience of testing at home without the need to visit a healthcare facility.
Global Home Blood Testing Devices Market Analysis
The home blood testing devices market demand is driven by the increased application and demand of at home devices. Due to the changing lifestyles and increasing health expenditures, people now prefer self-performing activities that could be performed without the presence of a healthcare professional. Hence, the demand for home blood testing devices has increased.
The increasing technological advancement in the development of home blood testing devices to acquire accurate and reliable results is also driving the market growth globally. The practice to reduce the size of these devices is also going on with the integration of digital platforms to manage the data and analyze it in real time. In August 2023, Vital Bio unveiled their new product VitalOne, that could interpret the test results of smaller blood samples in just 20 minutes. Such technologies are contributing to market growth significantly.
The increasing integration of home blood testing devices with wearable devices, such as smartwatches and fitness trackers, is also gaining popularity and driving the market growth. With the help of this integration continuous monitoring of health parameters and seamless data sharing between devices is possible which enhances the overall healthcare experience for individuals.
There is a significant rise in the home blood testing devices market value with the arrival novel technologies like bloodless blood tests in the market. General Prognostics is developing the potentially lifesaving bloodless blood tests technology that detects the changing trends in a patient’s body, even before they show symptoms. Based on artificial intelligence (AI), such tests utilise digital biomarkers with blood biomarkers to provide timely, clinically significant information about the condition of heart failure patients.
Global Home Blood Testing Devices Market Segmentation
Market Breakup by Type
- Glucose Test Kits
- Infectious Diseases Test Kits
- Cholesterol Test Strips
- Drugs of Abuse Test Kits
- Coagulation Monitoring Tests
- Others
Market Breakup by Age Group
- Pediatric
- Adult
- Geriatric
Market Breakup by Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Home Blood Testing Devices Market Overview
With the rising prevalence of chronic diseases, North America, especially the United States, has led the home blood testing devices market share in the historical period. The increased focus on preventive healthcare and well-equipped infrastructure to adapt with the technological advancements have majorly driven the market growth.
In Europe, owing to the increased efforts of the government and influential healthcare companies, at home blood testing has become normal in common households. With a robust healthcare ecosystem, the region is a major consumer of such testing devices and is estimated to have a large market share in the forecast period as well.
To meet the high home blood testing devices market demand, the companies present in the Asia-Pacific region have boosted the production of such devices. With a substantial portion of geriatric population, the region is witnessing a high number of cholesterol level, hemoglobin, blood pressure level testing. In addition, the governments are also proactive in spreading awareness and educating the population about the benefits and application of these tools.
Global Home Blood Testing Devices Market: Competitor Landscape
The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- ACON Laboratories Inc
- Quidel Corporation
- OraSure Technologies Inc
- Cardinal Health Inc
- PHC Holdings Corporation
- B. Braun Melsungen AG
- Abbott Laboratories
- Biomerieux SA
- F. Hoffmann-La-Roche Ltd
- Everly Health Inc
- Walgreens
- D&A health
- Pts Disgnostics
- Trinity Biotech Plc
- Siemens Healthineers
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Age Group |
|
| Breakup by Distribution Channel |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Home Blood Testing Devices Market Overview
3.1 Global Home Blood Testing Devices Market Historical Value (2017-2023)
3.2 Global Home Blood Testing Devices Market Forecast Value (2024-2032)
4 Global Home Blood Testing Devices Market Landscape
4.1 Global Home Blood Testing Devices Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Home Blood Testing Devices Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Home Blood Testing Devices Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Home Blood Testing Devices Market Segmentation
6.1 Global Home Blood Testing Devices Market by Type
6.1.1 Market Overview
6.1.2 Glucose Test Kits
6.1.3 Infectious Diseases Test Kits
6.1.4 Cholesterol Test Strips
6.1.5 Drugs of Abuse Test Kits
6.1.6 Coagulation Monitoring Tests
6.1.7 Others
6.2 Global Home Blood Testing Devices Market by Age Group
6.2.1 Market Overview
6.2.2 Pediatric
6.2.3 Adult
6.2.4 Geriatric
6.3 Global Home Blood Testing Devices Market by Distribution Channel
6.3.1 Market Overview
6.3.2 Hospital Pharmacy
6.3.3 Retail Pharmacy
6.3.4 Online Pharmacy
6.3.5 Others
6.4 Global Home Blood Testing Devices Market by Region
6.4.1 Market Overview
6.4.2 North America
6.4.3 Europe
6.4.4 Asia Pacific
6.4.5 Latin America
6.4.6 Middle East and Africa
7 North America Home Blood Testing Devices Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Home Blood Testing Devices Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Home Blood Testing Devices Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Home Blood Testing Devices Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Home Blood Testing Devices Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Patent Analysis
12.1 Analysis by Type of Patent
12.2 Analysis by Publication year
12.3 Analysis by Issuing Authority
12.4 Analysis by Patent Age
12.5 Analysis by CPC Analysis
12.6 Analysis by Patent Valuation
12.7 Analysis by Key Players
13 Grants Analysis
13.1 Analysis by year
13.2 Analysis by Amount Awarded
13.3 Analysis by Issuing Authority
13.4 Analysis by Grant Application
13.5 Analysis by Funding Institute
13.6 Analysis by NIH Departments
13.7 Analysis by Recipient Organization
14 Funding Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Partnership and Collaborations Analysis
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Regulatory Framework
16.1 Regulatory Overview
16.1.1 US FDA
16.1.2 EU EMA
16.1.3 INDIA CDSCO
16.1.4 JAPAN PMDA
16.1.5 Others
17 Supplier Landscape
17.1 ACON Laboratories Inc
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 Quidel Corporation
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 OraSure Technologies Inc
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Cardinal Health Inc
17.4.1 Financial Analysis
17.4.2 Financial Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 PHC Holdings Corporation
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 B. Braun Melsungen AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Abbott Laboratories
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Biomerieux SA
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 F. Hoffmann-La-Roche Ltd
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 Everly Health Inc
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Walgreens
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 D&A health
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Pts Disgnostics
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Trinity Biotech Plc
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 Siemens Healthineers
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
18 Global Home Blood Testing Devices Market - Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
Key Questions Answered in the Report
The market attained a value of about USD 16.4 billion in 2023, driven by the rising incidence of diabetes cases across the globe.
The market is anticipated to grow at a CAGR of 10.7% during the forecast period of 2024-2032, likely to reach a market value of USD 41.1 billion by 2032.
The market demand is driven by the increasing incidence of chronic diseases and rising familiarity of masses with at home tests.
The current market trend is integration of digital and artificial intelligence enabled tools for accurate and rapid results. In August 2023, Vital Bio released their new product VitalOne, that could interpret the test results of smaller blood samples in just 20 minutes.
Glucose test kits, infectious diseases test kits, cholesterol test strips, drugs of abuse test kits, coagulation monitoring tests and others are some common types.
Based on age, the market is divided pediatric, adult, and geriatrics.
Major distribution channels include hospital pharmacies, retail pharmacies, and online pharmacies, among others.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Key players involved in the market are ACON Laboratories Inc., Quidel Corporation, OraSure Technologies Inc., Cardinal Health Inc., PHC Holdings Corporation, B. Braun Melsungen AG, Abbott Laboratories, Biomerieux SA, F. Hoffmann-La-Roche Ltd., Everly Health Inc., Walgreens, D&A health, Pts Disgnostics, Trinity Biotech Plc, and Siemens Healthineers.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER